Align Technology | ALGN - Equity Capital And Reserves


Align Technology reported $4.23B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
3M USD 2.95B 311M Jun/2026
Align Technology USD 4.23B 83.03M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bruker USD 2.5B 46.3M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
CVS Health USD 79.7B 2.25B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
Henry Schein USD 3.16B 109M Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
McKesson USD -4.24B 2.07B Jun/2026
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Solventum Corp USD 4.8B 169M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Teleflex USD 2.9B 179.9M Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Veeva Systems USD 7.3B 89.6M Mar/2026
Waters USD 15.29B 12.73B Mar/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026
Zoetis USD 3.15B 85M Jun/2026